Related Experiment Videos
Long-term survival after orthotopic and heterotopic cardiac transplantation
Insights
Long-term heart transplant survivors demonstrate good quality of life years after orthotopic and heterotopic procedures. Despite minimal rejection and HLA matching, patients lead active lives, highlighting transplantation
Area of Science:
- Cardiology
- Immunology
- Transplantation Medicine
Background:
- Investigating long-term outcomes of heart transplantation is crucial for understanding patient survival and quality of life.
- Assessing different surgical approaches, including orthotopic and heterotopic heart transplantation, provides insights into their respective efficacies.
- Evaluating the impact of factors like rejection episodes, blood transfusions, and human leukocyte antigen (HLA) matching on transplant success is essential.
Observation:
- Five long-term heart transplant survivors were studied, with two having undergone orthotopic transplantation over 9 and 11 years prior.
- Three patients received heterotopic heart transplantation (left heart bypass or biventricular bypass) 4-6 years earlier.
- Most patients experienced limited acute rejection episodes and suboptimal HLA matching, with some receiving blood transfusions.
Findings:
- All five patients reported leading full and active lives, indicating a high quality of life post-transplantation.
- Two patients developed significant coronary artery disease, one severe, potentially linked to chronic immune-complex deposition.
- Despite potential complications, heart transplantation offers prolonged, good-quality survival.
Implications:
- Heart transplantation, while a major procedure, can lead to many years of active living for recipients.
- Further research into managing long-term complications like cardiac allograft vasculopathy is warranted.
- Optimizing immunosuppression and monitoring strategies may improve long-term outcomes and reduce complications after heart transplantation.
Abstract:
Five long-term survivors of heart transplantation were reinvestigated. Two patients had undergone orthotopic heart transplantation over 11 and 9 years earlier and constitute two of the world's longest-surviving patients after this procedure. Three patients had undergone heterotopic heart transplantation (one left heart bypass alone and two biventricular bypass) four to six years earlier. Four of the five patients had had only one or no documented acute rejection episodes. Three had been given blood transfusions. None had had particularly good tissue matching in relation to the donor on HLA typing. All five patients were leading full and active lives. At review two patients had significant coronary artery disease, one severe, presumably due to chronic immune-complex deposition. Heart transplantation remains a major undertaking, but it can offer the patient many years of good-quality life.